SUNSHINE BIOPHARMA INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e0ed87ea-6db7-4225-9428-46b0d693df44/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-6.0M | 2025-01-01 – 2025-12-31 | evidence 0001683168-26-002644 |
| FY 2024 | $-5.1M | 2024-01-01 – 2024-12-31 | evidence 0001683168-25-002184 |
| FY 2023 | $-4.5M | 2023-01-01 – 2023-12-31 | evidence 0001683168-24-001818 |
| FY 2022 | $-26.7M | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-002128 |
| FY 2021 | $-12.4M | 2021-01-01 – 2021-12-31 | evidence 0001683168-22-001788 |
| FY 2020 | $-2.8M | 2020-01-01 – 2020-12-31 | evidence 0001654954-21-003507 |
| FY 2019 | $-1.7M | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-004731 |
| FY 2018 | $-2.2M | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-004354 |
| FY 2017 | $-1.0M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003495 |
| FY 2016 | $-3.5M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-003365 |
| FY 2015 | $-1.7M | 2015-01-01 – 2015-12-31 | evidence 0001354488-16-006700 |
| FY 2014 | $-1.9M | 2014-01-01 – 2014-12-31 | evidence 0001354488-15-001081 |
| FY 2013 | $-6.0M | 2009-08-17 – 2014-03-31 | evidence 0001354488-14-002379 |
| FY 2012 | $-4.5M | 2009-08-17 – 2013-03-31 | evidence 0001354488-13-002516 |
| FY 2011 | $-2.3M | 2009-08-17 – 2012-03-31 | evidence 0001354488-12-002208 |
| FY 2010 | $-1.8M | 2009-08-17 – 2011-03-31 | evidence 0001354488-11-001463 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SUNSHINE BIOPHARMA INC. — all facts · Revenue · Operating Income